In association with
Webinar: Tuesday, 20 June, 2023 · 10:30 AM – 11:15 AM
That medicine use should deliver value is beyond debate but there is much less agreement about just how that value should be defined and measured.
It is accepted that assessing value means more than simply looking at the price tag of a medicine. A cheap medicine that is difficult for patients to take as prescribed – leading to a worsening of condition and need for other healthcare interventions – is clearly a false economy. Medicines optimisation is therefore increasingly seen as requiring a holistic approach, with all relevant healthcare professionals involved alongside – crucially – patients themselves.
The idea is that patients should be a key part of helping decide which medicines work best for them. Put another way: a key part of helping to decide which medicines are most valuable to them.
But where does the balance lie in this complicated value equation? How should value ultimately be assessed, measured and reported on? And what does effective medicines optimisation mean across an integrated care system?
This HSJ webinar, run in association with Spirit Health, will bring together a small panel to consider these complicated issues.
To register, please click here.
Speakers
Selma Abed, head of medicines optimisation, Spirit Health
Selma Abed is a medicines optimisation and management specialist with experience across the NHS – including community pharmacy, primary and secondary care – as well as in the private sector. At Spirit Health, she leads the medicines optimisation national team, designing and implementing patient-centred medicines optimisation programmes for ICSs. These serve to drive efficiencies across ICSs.
Yousaf Ahmad, director of medicines optimisation and chief pharmacist, Frimley ICS
Yousaf Ahmad is director of medicines optimisation and chief pharmacist at Frimley ICS, which covers a population of more than 800,000 people in East Berkshire, North East Hampshire and Farnham and Surrey Heath. He has worked in pharmacy and the wider pharmaceutical industry for more than 20 years and has extensive experience in secondary care, having worked primarily in large acute health boards in Scotland and the Middle East. Mr Ahmad is a fellow of the Royal Pharmaceutical Society and a member of the governing council of the General Pharmaceutical Council.
Claire Read, chair, HSJ
Claire Read is a professional writer and editor who has specialised in healthcare throughout her 20-year career. She has been a regular contributor to HSJ since 2012 and has a particular interest in healthcare digitisation and technology.
